|Tested species reactivity||Human, Mouse|
|Published species reactivity||Mouse|
|Host / Isotype||Rabbit / IgG|
|Immunogen||Recombinant fragment corresponding to a region within amino acids 169 and 444 of ATP6V1H (Uniprot ID#Q9UI12)|
|Purification||Antigen affinity chromatography|
|Storage buffer||0.1M tris glycine, pH 7, with 10% glycerol|
|Storage Conditions||-20° C, Avoid Freeze/Thaw Cycles|
|Tested Applications||Dilution *|
|Immunohistochemistry (Paraffin) (IHC (P))||Assay-Dependent|
|Western Blot (WB)||1:500-1:3000|
* Suggested working dilutions are given as a guide only. It is recommended that the user titrate the product for use in their own experiment using appropriate negative and positive controls.
|Western Blot (WB)||See 1 publications below|
PA5-22134 targets V-ATPase H in Western blot applications and shows reactivity with Human and mouse samples.
The PA5-22134 immunogen is recombinant protein fragment contain a sequence corresponding to a region within amino acids 169 and 444 (Q9UI12) of ATP6V1H.
For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.
Combined LRRK2 mutation, aging and chronic low dose oral rotenone as a model of Parkinson's disease.
PA5-22134 was used in western blot to study the effects of genetic background, natural aging, and prolonged oral administration of rotenone to mutant knock in LRRK2 mice
|Liu HF,Ho PW,Leung GC,Lam CS,Pang SY,Li L,Kung MH,Ramsden DB,Ho SL||Scientific reports (7:null)||2017|